Top Story

Exercise response, epigenetic profiles key in improving type 2 diabetes interventions

November 21, 2014

Read the Perspective from Gerald Bernstein, MD, FACP

Investigating exercise resistance mechanisms would lead to better understanding of how training efforts relate to type 2 diabetes and potentially allow targeted and new interventions, according to findings published in The Journal of Clinical Endocrinology & Metabolism.

Through a systematic review of classic and contemporary primary reports, Lauren M. Sparks, PhD, and Natalie A. Stephens, PhD, both of the Translational Research Institute for Metabolism and Diabetes at Florida Hospital in Orlando, said research would improve outcomes for patients at all levels of exercise response.

In the Journals

Clinical practice guideline published for Paget's disease diagnosis, treatment

November 20, 2014
A clinical practice guideline for the diagnosis and treatment of Paget’s disease of the bone has recently been released by the Endocrine Society and has been…
John Randolph In the Journals

Reproductive hormones modestly linked to sexual function during menopause

November 20, 2014
Modest significant associations were observed between reproductive hormones and sexual function in women during menopause, according to research published in The

NIH renews research grants on aging

November 20, 2014
The NIH has announced renewed funding of $23.4 million for 11 Edward R. Roybal Centers for Research on Applied Gerontology and the designation of two additional…
Marcus Lind In the JournalsPerspective

Patients with type 1 diabetes at increased risk for all-cause, CVD mortality

November 20, 2014
The likelihood of dying from any cause or cardiovascular causes is two times higher in patients with type 1 diabetes and an HbA1c level ≤6.9% compared with…
More News Headlines »
Screening and Treatment of Diabetes-Associated Eye Disease

Screening and Treatment of Diabetes-Associated Eye Disease: Out of Sight, Out of Mind?

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Diabetic retinopathy is a major cause of blindness among adults aged 40 years and older. Optimal outcomes necessitates…
More »
Meeting News Coverage Video
thumbnail for video 3886443649001

Risk stratification guidelines help determine treatment for thyroid cancer

November 11, 2014
Fabian Pitoia, MD,  head of the thyroid section of the division of endocrinology at the Hospital de Clinicas of…
More »
Experts Take: Dialogue on HTG

Experts’ Take: Dialogue on Hypertriglyceridemia

This activity is supported by an independent educational grant from Amarin Pharma Inc.

Lead by genetic studies, recent data describe a causal role of triglycerides (TG) in the formation of atherosclerosis…
More »